Newest Titles

• Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone for the treatment of high-risk newly diagnosed multiple myeloma
  Article (Journal), Online Resource
• Plain language summary of isatuximab plus carfilzomib, lenalidomide, and dexamethasone for the treatment of people with high-risk newly diagnosed multiple myeloma
  Article (Journal), Online Resource
• The proteogenomic landscape of multiple myeloma reveals insights into disease biology and therapeutic opportunities
  Article (Journal), Online Resource
• The remission status of AML patients after allo-HCT is associated with a distinct single-cell bone marrow T-cell signature
  Article (Journal), Online Resource
• Multiple myeloma long-term survivors exhibit sustained immune alterations decades after first-line therapy
  Article (Journal), Online Resource

see all (89)
Alle anzeigen (incl. other editions/formats) (91)

Related Authors

• Goldschmidt, Hartmut
• Ho, Anthony Dick
• Hose, Dirk
• Raab, Marc-Steffen
• Müller-Tidow, Carsten

see all (1061)

Publication Timeline

Publication Formats